ID: ALA5188787

Max Phase: Preclinical

Molecular Formula: C30H39BrN2O6

Molecular Weight: 603.55

Representations

Canonical SMILES:  C=C[C@]1(C)C[C@@H](OC(=O)CNC(=O)NC(=O)c2ccc(Br)cc2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O

Standard InChI:  InChI=1S/C30H39BrN2O6/c1-6-28(4)15-22(39-23(35)16-32-27(38)33-26(37)19-7-9-20(31)10-8-19)29(5)17(2)11-13-30(18(3)25(28)36)14-12-21(34)24(29)30/h6-10,17-18,22,24-25,36H,1,11-16H2,2-5H3,(H2,32,33,37,38)/t17-,18+,22-,24+,25+,28-,29+,30+/m1/s1

Standard InChI Key:  KQAKOWRKZQVVIQ-POGRXDPOSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 603.55

Molecular Weight (Monoisotopic): 602.1991

AlogP: 4.80

#Rotatable Bonds: 5

Polar Surface Area: 121.80

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 10.59

CX Basic pKa:

CX LogP: 4.59

CX LogD: 4.59

Aromatic Rings: 1

Heavy Atoms: 39

QED Weighted: 0.33

Np Likeness Score: 0.98

References

1. Wu G, Zhu Z, Li J, Luo X, Zhu W, Liao G, Xia J, Zhang W, Pan W, Li T, Wu S..  (2022)  Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.,  59  [PMID:35220163] [10.1016/j.bmc.2022.116676]

Source

Source(1):

• Scientific Literature